Zimmer Biomet Holdings (NYSE:ZBH) has had a rough month with its share price down 5.4%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look ...

Principal Securities Inc. boosted its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 23.7% in ...

Principal Financial Group Inc. lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 4.0% ...

Zimmer Biomet is suffering due to macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations.

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is $2.31, expectations were $2.3. Operator: Good morning, ladies and gentlemen, ...

Shares of Zimmer Biomet Holdings Inc. ZBH slipped 1.43% to $98.98 Tuesday, on what proved to be an all-around great trading ...